Variables | Hemodynamic fluctuation | P value | |||
---|---|---|---|---|---|
≥30% (n = 482) | No.a | < 30% (n = 1615) | No.a | ||
Demographic and lifestyle-related | |||||
Age (years), mean (range) | 61.2 (18–96) | 0 | 58.3 (18–93) | 0 | < 0.001 |
Female sex, n (%) | 247 (51.2) | 0 | 813 (50.3) | 0 | 0.73 |
Height (cm), mean (95% CI) | 160.5 (159.7–161.4) | 0 | 161.0 (160.6–161.5) | 3 | 0.29 |
Weight (kg), mean (95% CI) | 59.3 (58.1–60.5) | 0 | 60.1 (59.5–60.8) | 0 | 0.23 |
BMI, n (%) | 0 | 3 | 0.23 | ||
< 18 | 48 (29.6) | 114 (70.4) | |||
≥ 18, < 25 | 316 (22.4) | 1093 (77.6) | |||
≥25, < 35 | 110 (22.5) | 379 (77.5) | |||
≥ 35 | 8 (23.5) | 26 (76.5) | |||
Smoking history, n (%) | 226 (46.9) | 0 | 721 (44.8) | 5 | 0.42 |
Physical status | |||||
ASA-PS scale, n (%) | 0 | 0 | 0.52 | ||
1 or 2 | 417 (86.5) | 1415 (87.6) | |||
3 or 4 | 65 (13.5) | 200 (12.4) | |||
Low exercise tolerability, n (%) | 32 (6.7) | 1 | 91 (5.7) | 5 | 0.41 |
Clinical and laboratory data | |||||
Arterial BP (mmHg) in the ward, mean (95% CI) | |||||
Systolic BP | 125 (123–126) | 15 | 125 (124–126) | 49 | 0.92 |
Diastolic BP | 74 (73–75) | 16 | 74 (74–75) | 51 | 0.82 |
History of steroid use, n (%) | 28 (5.8) | 1 | 96 (6.0) | 5 | 0.91 |
History of opioid use, n (%) | 3 (0.6) | 1 | 13 (0.8) | 5 | 1.00b |
Antithrombotic drug use, n (%) | 66 (13.7) | 1 | 184 (11.4) | 5 | 0.17 |
Anemia, n (%) | 172 (35.8) | 1 | 573 (35.5) | 2 | 0.93 |
Electrolyte imbalance, n (%) | 4 (0.8) | 3 | 12 (0.8) | 6 | 0.77b |
Hypoalbuminemia, n (%) | 70 (14.6) | 3 | 191 (11.9) | 6 | 0.11 |
Elevated CRP, n (%) | 133 (27.9) | 5 | 413 (25.8) | 14 | 0.36 |